Liu, Jie https://orcid.org/0000-0002-5264-4612
Pong, Annpey
Gallo, Silvina
Darekar, Amanda
Terra, Steven G.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
https://doi.org/10.1186/s12933-019-0856-7
Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
https://doi.org/10.1007/s13300-020-00867-1
Documents that mention this clinical trial
A Pooled Analysis of the Efficacy and Safety of Ertugliflozin as Add-On Therapy to Metformin
https://doi.org/10.2337/db18-1140-p
Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
https://doi.org/10.1186/s12933-019-0856-7
Efficacy and Safety of Ertugliflozin Added to Metformin: A Pooled Population from Asia with Type 2 Diabetes and Overweight or Obesity
https://doi.org/10.1007/s13300-022-01345-6
Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
https://doi.org/10.1007/s13300-020-00867-1
Documents that mention this clinical trial
A Pooled Analysis of the Efficacy and Safety of Ertugliflozin as Add-On Therapy to Metformin
https://doi.org/10.2337/db18-1140-p
Effect of ertugliflozin on blood pressure in patients with type 2 diabetes mellitus: a post hoc pooled analysis of randomized controlled trials
https://doi.org/10.1186/s12933-019-0856-7
Effects of Ertugliflozin on Liver Enzymes in Patients with Type 2 Diabetes: A Post-Hoc Pooled Analysis of Phase 3 Trials
https://doi.org/10.1007/s13300-020-00867-1
Funding for this research was provided by:
Merck Sharp & Dohme Corp.
Pfizer
Article History
Received: 22 January 2019
Accepted: 8 April 2019
First Online: 7 May 2019